Trails Edge Capital Partners, LP on CTNM, Oct 22, 2026
Trails Edge Capital Partners, LP now owns 5.1%, as a passive investor.
- Date
- Oct 22, 2026
- Who
- Trails Edge Capital Partners, LP
- Fund
- CTNM - Contineum Therapeutics
- Stake
- 5.1% (1,679,443 shares)
- Type of notice
- Passive investor
- Document number
- 0001493152-26-048104
Open the original document at the SEC →
We read this document automatically. If something looks wrong, the original is the one that counts.